London, 2025 — Claritas Intelligence has published its global market report on psychological assessment software, sizing the market at USD 5.8 billion in 2025 and projecting, under the base case, growth to USD 11.7 billion by 2033, a compound annual rate of 9.2% over the 2025–2033 forecast period.
The epidemiological foundation for demand is unusually well-documented. The GBD Study 2021, which quantified mental and neurological conditions among the leading contributors to years lived with disability and DALYs across 204 countries, has materially shifted payer and policy attention toward upstream screening infrastructure. That burden is a secular, structural pressure, not a post-pandemic cyclical effect. At the same time, the FDA's evolving Software as a Medical Device framework and the EMA's IVDR transition create conflicting compliance obligations for cross-border vendors, and the report identifies regulatory fragmentation as the single most critical risk to market participants operating across jurisdictions.
On the demand side, two pharmaceutical-sector catalysts stand out. FDA approvals of amyloid-targeting Alzheimer's therapeutics (lecanemab, NDA 761269, January 2023; donanemab, BLA 761248, July 2024) require MCI-to-mild-Alzheimer's cognitive staging as a prescribing prerequisite, generating direct pull-through demand for validated cognitive assessment software at neurologist and memory clinic practice points. Separately, CMS expansion of behavioral health integration CPT codes (99484, 99492–99494) has broadened billable use cases for digitally administered assessments in primary care. The U.S. health expenditure base, at USD 13,473 per capita in 2023, creates the deepest reimbursement pool globally for these services. North America holds an estimated 38% market share in 2025, a position reinforced by established SaMD regulatory pathways and that per-capita spending advantage.
AI-driven adaptive testing modules represent the fastest-growing product segment, with the report projecting a segment CAGR of 13.1% through 2033 under the base case. Explainable AI mandates are increasingly the decisive differentiator for institutional procurement, following the 2023 consensus on trustworthy AI frameworks. Multimodal assessment capabilities spanning natural language processing, voice analysis, and physiological signals are expanding clinical utility, though platforms lacking decades of normative data face meaningful barriers against incumbents. The conventional growth thesis centered on telepsychiatry and post-pandemic awareness may, the report argues, underweight a more durable driver: forensic and occupational assessment mandates in aviation, nuclear power, and financial services, which are largely recession-resistant and carry substantial switching costs.
Asia Pacific is the fastest-growing regional market. China's health expenditure of 5.94% of GDP represents structural underinvestment relative to OECD peers, yet digital-first rollout economics favor rapid platform penetration following NMPA clearance. Academic publication volume on psychological assessment software surpassed 286,000 indexed works as of 2024, signaling a research-to-commercialization pipeline with few parallels in adjacent health-tech niches.
"The market's tripartite demand structure, spanning SaMD-regulated health technology, EEOC-governed enterprise HR tooling, and academic research instruments, is consistently underappreciated when analysts benchmark it solely against digital health multiples. The platforms with the deepest normative databases and the clearest XAI compliance architecture are best positioned to capture institutional procurement, regardless of where the macro cycle sits." — Ananya Sharma, Senior Analyst, Claritas Intelligence
Key companies profiled in the report include Pearson plc, Psychological Assessment Resources (PAR), Hogan Assessment Systems, SIGMA Assessment Systems, Wonderlic, Kaplan, SHL Group, MHS Assessments (Multi-Health Systems), Western Psychological Services, Mindtickle, Criterion International, and Mapi Research Trust.
About Claritas Intelligence: Claritas Intelligence is a market intelligence publisher specializing in quantitative demand forecasting and competitive landscape analysis across healthcare, technology, and adjacent sectors. Its reports are designed to support strategic planning, investment due diligence, and commercial decision-making for clients operating in global markets.
The full analysis, including segmentation, regional breakdowns, forecasts, and company profiles, is available in the Psychological Assessment Softwares Market Report.
“The global psychological assessment software market is valued at USD 5.8B in 2025 and the report projects it reaches USD 11.7B by 2033, advancing at a 9.2% CAGR.”
Ananya Sharma
Senior Research Analyst – Healthcare & Life Sciences